The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone

scientific article published on 01 September 2008

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/13547500802445199
P698PubMed publication ID18830857

P2093author name stringJ Mark Skehel
John B Davis
Allen D Roses
Paul Cutler
Ann M Saunders
Steven M Fox
David Hosford
Israel S Gloger
Neil A Jones
Christina M Nock
Emma E Kinsey
Emma L Akuffo
Marjorie A Smith
P433issue6
P921main subjectAlzheimer's diseaseQ11081
(RS)-rosiglitazoneQ424771
biomarkerQ864574
P304page(s)618-636
P577publication date2008-09-01
P1433published inBiomarkersQ4915076
P1476titleThe discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone
P478volume13

Reverse relations

cites work (P2860)
Q51760901A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.
Q36966044Alzheimer's disease: are blood and brain markers related? A systematic review
Q37383709Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects
Q33824444Blood-based biomarkers of Alzheimer's disease: challenging but feasible
Q37878285Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
Q34135724Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions
Q38060638Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer?
Q42322507Microglia, Alzheimer's disease, and complement
Q34556953Plasma proteins predict conversion to dementia from prodromal disease
Q36767124Plasma proteomics for the identification of Alzheimer disease
Q33804415Serping1/C1 Inhibitor Affects Cortical Development in a Cell Autonomous and Non-cell Autonomous Manner
Q35191570Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma
Q38060574Use of proteomic methods in the analysis of human body fluids in Alzheimer research

Search more.